null

SMILES: NC(=O)c1ccc(cc1)-c1ccc(cc1)N1CCCC(NC(=O)Nc2ccc(cc2)C(F)(F)F)C1=O

InChI Key: InChIKey=JAIACGWEUZCMCM-UHFFFAOYSA-N

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 454184   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
N-formyl peptide receptor 2 (Homo sapiens (Human))	BDBM454184 (US10717708, Example 48 | US11186544, Example 48) Show SMILES NC(=O)c1ccc(cc1)-c1ccc(cc1)N1CCCC(NC(=O)Nc2ccc(cc2)C(F)(F)F)C1=O Show InChI InChI=1S/C26H23F3N4O3/c27-26(28,29)19-9-11-20(12-10-19)31-25(36)32-22-2-1-15-33(24(22)35)21-13-7-17(8-14-21)16-3-5-18(6-4-16)23(30)34/h3-14,22H,1-2,15H2,(H2,30,34)(H2,31,32,36)	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	560	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...				US Patent US10717708 (2020)
					More data for this Ligand-Target Pair
fMet-Leu-Phe receptor (Homo sapiens (Human))	BDBM454184 (US10717708, Example 48 | US11186544, Example 48) Show SMILES NC(=O)c1ccc(cc1)-c1ccc(cc1)N1CCCC(NC(=O)Nc2ccc(cc2)C(F)(F)F)C1=O Show InChI InChI=1S/C26H23F3N4O3/c27-26(28,29)19-9-11-20(12-10-19)31-25(36)32-22-2-1-15-33(24(22)35)21-13-7-17(8-14-21)16-3-5-18(6-4-16)23(30)34/h3-14,22H,1-2,15H2,(H2,30,34)(H2,31,32,36)	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem		n/a	n/a	n/a	n/a	930	n/a	n/a	n/a	n/a
TBA									Citation and Details
					More data for this Ligand-Target Pair
N-formyl peptide receptor 2 (Homo sapiens (Human))	BDBM454184 (US10717708, Example 48 | US11186544, Example 48) Show SMILES NC(=O)c1ccc(cc1)-c1ccc(cc1)N1CCCC(NC(=O)Nc2ccc(cc2)C(F)(F)F)C1=O Show InChI InChI=1S/C26H23F3N4O3/c27-26(28,29)19-9-11-20(12-10-19)31-25(36)32-22-2-1-15-33(24(22)35)21-13-7-17(8-14-21)16-3-5-18(6-4-16)23(30)34/h3-14,22H,1-2,15H2,(H2,30,34)(H2,31,32,36)	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem		n/a	n/a	n/a	n/a	560	n/a	n/a	n/a	n/a
TBA									Citation and Details
					More data for this Ligand-Target Pair
fMet-Leu-Phe receptor (Homo sapiens (Human))	BDBM454184 (US10717708, Example 48 | US11186544, Example 48) Show SMILES NC(=O)c1ccc(cc1)-c1ccc(cc1)N1CCCC(NC(=O)Nc2ccc(cc2)C(F)(F)F)C1=O Show InChI InChI=1S/C26H23F3N4O3/c27-26(28,29)19-9-11-20(12-10-19)31-25(36)32-22-2-1-15-33(24(22)35)21-13-7-17(8-14-21)16-3-5-18(6-4-16)23(30)34/h3-14,22H,1-2,15H2,(H2,30,34)(H2,31,32,36)	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	930	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...				US Patent US10717708 (2020)
					More data for this Ligand-Target Pair